» Articles » PMID: 9557871

NetOglyc: Prediction of Mucin Type O-glycosylation Sites Based on Sequence Context and Surface Accessibility

Overview
Journal Glycoconj J
Publisher Springer
Date 1998 Apr 29
PMID 9557871
Citations 155
Authors
Affiliations
Soon will be listed here.
Abstract

The specificities of the UDP-GalNAc:polypeptide Nacetylgalactosaminyltransferases which link the carbohydrate GalNAc to the side-chain of certain serine and threonine residues in mucin type glycoproteins, are presently unknown. The specificity seems to be modulated by sequence context, secondary structure and surface accessibility. The sequence context of glycosylated threonines was found to differ from that of serine, and the sites were found to cluster. Non-clustered sites had a sequence context different from that of clustered sites. Charged residues were disfavoured at position -1 and +3. A jury of artificial neural networks was trained to recognize the sequence context and surface accessibility of 299 known and verified mucin type O-glycosylation sites extracted from O-GLYCBASE. The cross-validated NetOglyc network system correctly found 83% of the glycosylated and 90% of the non-glycosylated serine and threonine residues in independent test sets, thus proving more accurate than matrix statistics and vector projection methods. Predictions of O-glycosylation sites in the envelope glycoprotein gp120 from the primate lentiviruses HIV-1, HIV-2 and SIV are presented. The most conserved O-glycosylation signals in these evolutionary-related glycoproteins were found in their first hypervariable loop, V1. However, the strain variation for HIV-1 gp120 was significant. A computer server, available through WWW or E-mail, has been developed for prediction of mucin type O-glycosylation sites in proteins based on the amino acid sequence. The server addresses are http://www.cbs.dtu.dk/services/NetOGlyc/ and netOglyc@cbs.dtu.dk.

Citing Articles

Enhanced O-glycosylation site prediction using explainable machine learning technique with spatial local environment.

Hong S, Chattaraj K, Guo J, Trout B, Braatz R Bioinformatics. 2025; 41(2).

PMID: 39878910 PMC: 11814488. DOI: 10.1093/bioinformatics/btaf034.


Unraveling -Glycan Diversity of Mucins: Insights from SmE Mucinase and Ultraviolet Photodissociation Mass Spectrometry.

Helms A, Chang V, Malaker S, Brodbelt J Anal Chem. 2024; 96(49):19230-19237.

PMID: 39576755 PMC: 11653425. DOI: 10.1021/acs.analchem.4c02011.


The Caenorhabditis elegans cuticle and precuticle: a model for studying dynamic apical extracellular matrices in vivo.

Sundaram M, Pujol N Genetics. 2024; 227(4.

PMID: 38995735 PMC: 11304992. DOI: 10.1093/genetics/iyae072.


Mass Spectrometry Strategies for -Glycoproteomics.

Helms A, Brodbelt J Cells. 2024; 13(5.

PMID: 38474358 PMC: 10930906. DOI: 10.3390/cells13050394.


Immunoinformatic Analysis of gp46 Protein and Potential Targets for Vaccination against Leishmaniasis.

Ahmadi M, Mamizadeh M, Siamian D, Touyeh M, Shams M, Rashidi Y Recent Adv Inflamm Allergy Drug Discov. 2024; 18(2):129-139.

PMID: 38318831 DOI: 10.2174/0127722708283588240124095057.


References
1.
Lund O, Engelbrecht J, Bohr H, Nielsen J, Hansen J . Prediction of O-glycosylation of mammalian proteins: specificity patterns of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase. Biochem J. 1995; 308 ( Pt 3):801-13. PMC: 1136796. DOI: 10.1042/bj3080801. View

2.
Voigt C, Adolf G . Natural human tumor necrosis factor beta (lymphotoxin). Variable O-glycosylation at Thr7, proteolytic processing, and allelic variation. FEBS Lett. 1992; 314(1):85-8. DOI: 10.1016/0014-5793(92)81467-z. View

3.
Kneller D, Cohen F, LANGRIDGE R . Improvements in protein secondary structure prediction by an enhanced neural network. J Mol Biol. 1990; 214(1):171-82. DOI: 10.1016/0022-2836(90)90154-E. View

4.
Robinson E, Appella E . Amino acid sequence of a mouse myeloma immunoglobin heavy chain (MOPC 47 A) with a 100-residue deletion. J Biol Chem. 1979; 254(22):11418-30. View

5.
Bock S, Skriver K, Nielsen E, Thogersen H, Wiman B, DONALDSON V . Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. Biochemistry. 1986; 25(15):4292-301. DOI: 10.1021/bi00363a018. View